Table C.5.

Result for the incidence of cholangiofibrosis after 2 years using model averaging

Model	Included covariate(s)	Number of parameters	Log‐likelihood	AIC	BMD	BMDL	BMDU	Converged	Accepted AIC
Null		1	−401.99	805.98	NA	NA	NA	Yes
Full		8	−44.50	105.00	NA	NA	NA	Yes
Logistic		2	−100.79	205.58	0.11	0.10	0.13	Yes	No
Log‐logistic		3	−60.70	127.40	0.11	0.09	0.12	Yes	No
Log‐probit		3	−66.76	139.52	0.10	0.09	0.11	Yes	No
Weibull		3	−89.97	185.94	0.08	0.07	0.09	Yes	No
Gamma		3	−78.53	163.06	0.10	0.08	0.11	Yes	No
Two‐stage		3	−93.07	192.14	0.10	0.09	0.11	No	No

AIC: Akaike information criterion; BMD: benchmark dose; BMDL: benchmark dose lower confidence limit; BMDU: benchmark dose upper confidence limit.